Fedora Pharmaceuticals Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$895K
Fedora Pharmaceuticals General Information
Description
Developer of novel antimicrobial agents designed to treat multidrug-resistant infections. The company's technology includes a beta-lactamase inhibitor that selectively and effectively inhibits beta-lactamases and restores the activity of the antibiotics, enabling the healthcare industry to boost antibiotic development to address antimicrobial resistance.
Contact Information
Website
www.fedorapharma.comCorporate Office
- 11629 105 Avenue NorthWest
- Edmonton, Alberta T5H 0L9
- Canada
Corporate Office
- 11629 105 Avenue NorthWest
- Edmonton, Alberta T5H 0L9
- Canada
Fedora Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 30-Apr-2025 | $895K | Completed | Generating Revenue | ||
| 2. Secondary Transaction - Private | Completed | Startup | ||||
| 1. Angel (individual) | 10-May-2013 | $197K | $197K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Fedora Pharmaceuticals Comparisons
Industry
Financing
Details
Fedora Pharmaceuticals Competitors (35)
One of Fedora Pharmaceuticals’s 35 competitors is Eligo Bioscience, a Venture Capital-Backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Eligo Bioscience | Venture Capital-Backed | Paris, France | ||||
| Venatorx Pharmaceuticals | Venture Capital-Backed | Malvern, PA | ||||
| NovaBiotics | Venture Capital-Backed | Aberdeen, United Kingdom | ||||
| Nosopharm | Formerly VC-backed | Lyon, France | ||||
| Prokaryotics | Corporation | Union, NJ |
Fedora Pharmaceuticals Signals
Fedora Pharmaceuticals FAQs
-
When was Fedora Pharmaceuticals founded?
Fedora Pharmaceuticals was founded in 2012.
-
Where is Fedora Pharmaceuticals headquartered?
Fedora Pharmaceuticals is headquartered in Edmonton, Canada.
-
What is the size of Fedora Pharmaceuticals?
Fedora Pharmaceuticals has 5 total employees.
-
What industry is Fedora Pharmaceuticals in?
Fedora Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Fedora Pharmaceuticals a private or public company?
Fedora Pharmaceuticals is a Private company.
-
What is Fedora Pharmaceuticals’s current revenue?
The current revenue for Fedora Pharmaceuticals is .
-
How much funding has Fedora Pharmaceuticals raised over time?
Fedora Pharmaceuticals has raised $1.09M.
-
Who are Fedora Pharmaceuticals’s competitors?
Eligo Bioscience, Venatorx Pharmaceuticals, NovaBiotics, Nosopharm, and Prokaryotics are some of the 35 competitors of Fedora Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process